Gene therapy may have its first blockbuster - The treatment by Novartis is able to save infants born with spinal muscular atrophy (SMA) type 1, a degenerative disease that usually kills within two years. But its expected cost is $1.5 and $2 million, the most expensive one-time medicine ever sold.
No comments:
Post a Comment